Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 24 min 44 sec ago

Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula

Thu, 10/15/2015 - 17:06
SAN JOSE, Calif., Oct. 15, 2015 -- (Healthcare Sales & Marketing Network) -- Teikoku Pharma USA Inc. ("TPU") today announced that it has entered into an exclusive license agreement with Eagle Pharmaceuticals, Inc. to market, sell, and distribute...
Biopharmaceuticals, Oncology, Licensing
Teikoku Pharma, Eagle Pharmaceuticals, Docetaxel

Biothera Appoints Dr. Jose Iglesias as Chief Medical Officer

Thu, 10/15/2015 - 15:31
EAGAN, Minn.--(Healthcare Sales & Marketing Network)--Biothera Pharmaceuticals, Inc., today announced the appointment of Jose Iglesias, M.D., as Chief Medical Officer. Dr. Iglesias will be responsible for clinical development, medical affairs, and other fu...
Biopharmaceuticals, Personnel
Biothera Pharmaceuticals, Imprime PGG

Nanovis Launches Expanded FortiCore Line of Interbody Fusion Devices at NASS

Thu, 10/15/2015 - 15:28
Proprietary Approach Layers Titanium Scaffold Surface Technology on PEEK Implants Creating Differentiated Devices CARMEL, Ind., Oct. 15, 2015 -- (Healthcare Sales & Marketing Network) -- Nanovis, a life sciences company committed to developing scientif...
Devices, Orthopaedic, Neurosurgery, Product Launch
Nanovis, FortiCore, interbody fusion

GenomeDx Biosciences Adds Tina Nova and Craig Johnson to Board of Directors

Thu, 10/15/2015 - 15:22
SAN DIEGO, Oct. 15, 2015 -- (Healthcare Sales & Marketing Network) -- GenomeDx Biosciences, a genomic information company, today announced that Tina Nova, Ph.D., and Craig Johnson have been appointed to its board of directors. "Tina and Craig each...
Diagnostics, Personalized Medicine, Oncology, Personnel
GenomeDx Biosciences, Prostate Cancer

Ovid Therapeutics Announces Appointment of Dr. Anna Kazanchyan to Senior Vice President, Business Development

Thu, 10/15/2015 - 15:19
NEW YORK--(Healthcare Sales & Marketing Network)--Ovid Therapeutics Inc. (Ovid), a privately held biopharmaceutical company focused on developing therapies for rare and orphan diseases of the brain, announced today the appointment of Anna Kazanchyan, M.D.,...
Biopharmaceuticals, Neurology, Personnel
Ovid Therapeutics

Kelly Londy Named Chief Operating Officer Of Accuray

Thu, 10/15/2015 - 15:17
SUNNYVALE, Calif., Oct. 15, 2015 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today that Kelly Londy, formerly chief commercial officer has been named chief operating officer of the Company effective immediately. Ms....
Devices, Oncology, Personnel
Accuray, TomoTherapy, radiosurgery, radiotherapy

Third Rock Ventures Launches Decibel Therapeutics with $52 Million Series A Financing to Discover New Medicines to Protect, Repair and Restore Hearing

Thu, 10/15/2015 - 15:14
Hearing disorders are major unmet medical need with little or no therapeutic options available to slow or reverse hearing loss; currently impact approximately 50 million people in the U.S. and severely hinder quality of life Decibel founders represent ...
Biopharmaceuticals, Venture Capital
Decibel Therapeutics, hearing loss

Impel NeuroPharma Closes First Tranche of Series B Financing

Wed, 10/14/2015 - 16:18
Impel raises Series B round to commercialize POD technology platform and Impel’s growing portfolio of enhanced CNS products SEATTLE--(Healthcare Sales & Marketing Network)--Impel NeuroPharma Inc., (Impel) today announced the first close in its Series B ...
Biopharmaceuticals, Neurology, Venture Capital
Impel NeuroPharma, Precision Olfactory Delivery, Alzheimers Disease

Jzaneen Lalani Joins Curemark as Chief Operating Officer

Wed, 10/14/2015 - 16:15
RYE, N.Y., Oct. 14, 2015 -- (Healthcare Sales & Marketing Network) -- Curemark, a drug research and development company focused on the treatment of neurological diseases for unmet medical needs, announced today the appointment of Jzaneen Lalani as Chief O...
Biopharmaceuticals, Neurology, Personnel
Curemark, Autism, Schizophrenia, Parkinson's disease

4WEB Medical Announces Launch of 3D Printed Posterior Spine Truss System

Wed, 10/14/2015 - 16:13
CHICAGO, Oct. 14, 2015 -- (Healthcare Sales & Marketing Network) -- 4WEB Medical announced today at the North American Spine Society annual meeting in Chicago that the company has launched its Posterior Spine Truss System in the U.S. market. The Posterio...
Devices, Orthopaedic, Neurosurgery, Product Launch
4WEB Medical, Posterior Spine Truss, interbody fusion

Medical Device Firm iTraumaCare Launches Updated Version of iTClamp Hemorrhage Control System

Wed, 10/14/2015 - 16:10
SAN ANTONIO--(Healthcare Sales & Marketing Network)--iTraumaCare®, an early-stage medical device firm focused on developing traumatic injury solutions for first responder, emergency medicine and military medicine applications, has unveiled the newest i...
Devices, Product Launch
iTraumaCare, hemostasis, Hemorrhage

Bovie Medical Names Jay Ewers Chief Financial Officer

Wed, 10/14/2015 - 16:06
CLEARWATER, Fla.--(Healthcare Sales & Marketing Network)--Bovie Medical Corporation (“Bovie or the “Company”) (BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, announced today that it has na...
Devices, Surgery, Personnel
Bovie Medical, J-Plasma

Viamet Appoints Dr. Oren Cohen as Chief Medical Officer

Wed, 10/14/2015 - 16:03
Experienced Pharmaceutical Executive and Leading Expert in Clinical Development RESEARCH TRIANGLE PARK, N.C.--(Healthcare Sales & Marketing Network)--Viamet Pharmaceuticals, Inc. today announced the appointment of Oren Cohen, M.D., as Chief Medical Offi...
Biopharmaceuticals, Personnel
Viamet Pharmaceuticals, Metalloenzyme

IlluminOss Medical Appoints Manny Avila as Chief Executive Officer

Wed, 10/14/2015 - 16:01
Medical Device Industry Expert to Advance Business Strategy for Revolutionary Fracture Repair Technology EAST PROVIDENCE, RI--(Healthcare Sales & Marketing Network) - IlluminOss Medical, a commercial-stage medical device company focused on minimally inv...
Devices, Orthopaedic, Personnel
IlluminOss Medical, bone stabilization

Benvenue Medical Announces Commercial Availability of Luna(R) 3D Interbody Fusion System, 2015 Spine Technology Award

Wed, 10/14/2015 - 15:55
Luna Provides Least Invasive Approach to Spinal Fusion for Treatment of Symptomatic Degenerative Disc Disease CHICAGO--(Healthcare Sales & Marketing Network)--Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today an...
Devices, Orthopaedic, Neurosurgery, Product Launch
Benvenue Medical, Luna 3D, Interbody Fusion, spine surgery

MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors

Wed, 10/14/2015 - 15:51
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--MyoKardia, Inc., a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced the appointmen...
Biopharmaceuticals, Oncology, Personnel
MyoKardia, cardiomyopathy

Eclipse(TM) Treatment Planning Software from Varian Now Offers Robust Optimization and Proton Therapy Dose Calculation Tools

Wed, 10/14/2015 - 15:48
The latest software release, including the Acuros® proton therapy algorithm for faster, more accurate dose calculation, receives FDA 510(k) clearance PALO ALTO, Calif., Oct. 14, 2015 -- (Healthcare Sales & Marketing Network) -- Varian Medical Syste...
Devices, Oncology, FDA, Product Launch
Varian Medical Systems, Eclipse, Treatment Planning, radiotherapy

Galera Therapeutics Raises $37 Million in Series B Financing

Wed, 10/14/2015 - 15:44
Funding to Support Development of Clinical Stage Dismutase Mimetics in the Treatment of Cancer Patients MALVERN, Pa.--(Healthcare Sales & Marketing Network)--Galera Therapeutics, Inc., a clinical-stage biotech developing new treatments for cancer patien...
Biopharmaceuticals, Oncology, Venture Capital
Galera Therapeutics, Oral Mucositis, chemotherapy, radiotherapy

Kura Oncology Appoints Thomas Malley to Board of Directors

Wed, 10/14/2015 - 15:41
LA JOLLA, Calif., Oct. 14, 2015 -- (Healthcare Sales & Marketing Network) -- Kura Oncology, Inc. (KURO), a clinical stage biopharmaceutical company, today announced the appointment of Thomas Malley to its board of directors. "Tom has extensive know...
Biopharmaceuticals, Oncology, Personnel
Kura Oncology, tipifarnib, farnesyl transferase

Baxter Announces U.S. FDA Clearance for AMIA Automated Peritoneal Dialysis System with SHARESOURCE Connectivity Platform

Tue, 10/13/2015 - 16:16
System Includes Two-Way Remote Connectivity, Touchscreen Controls and Voice Guidance for Home Patients DEERFIELD, Ill.--(Healthcare Sales & Marketing Network)--Baxter International Inc. (BAX) announced today the United States Food and Drug Administratio...
Devices, FDA
Baxter, AMIA APD, peritoneal dialysis, ESRD

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong